Inventiv Health buy Riccardo
Start price
26.01.08
/
50%
€22.11
Target price
26.07.08
€24.00
Performance (%)
-28.09%
End price
26.07.08
€15.90
Summary
This prediction ended on 26.07.08 with a price of €15.90. The prediction for Inventiv Health disappointed with a performance of -28.09%. Riccardo has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Inventiv Health | - | - | - | - |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% | 113.046% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% | 68.687% |
Comments by Riccardo for this prediction
In the thread Inventiv Health diskutieren
InVentiv Health
inVentiv Health Inc. reported third-quarter adjusted operating income of $31.7 million, or 49 cents a share, topping the mean estimate of analysts polled by Thomson Financial of 44 cents a share. Revenue for the three months ended Sept. 30 rose 29% to $254.9 million, above Wall Street's $249.4 million estimate. A year earlier, the Somerset, N.J.-based provider of value-added services to the pharmaceuticals and life sciences industries posted revenue of $197.8 million.
(Laufzeit überschritten)